• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab.

作者信息

Sivapalaratnam Suthesh, Linpower Lisa, Sirigireddy Bala, Agapidou Alexandra, Jain Susan, Win Nay, Tsitsikas Dimitris A

机构信息

Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, UK.

Department of Haematology, University of Cambridge, Cambridge, UK.

出版信息

Br J Haematol. 2019 Sep;186(6):e212-e214. doi: 10.1111/bjh.16103. Epub 2019 Aug 1.

DOI:10.1111/bjh.16103
PMID:31368112
Abstract
摘要

相似文献

1
Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab.使用抗IL6R人源化单克隆抗体托珠单抗治疗镰状细胞病中的输血后高溶血综合征。
Br J Haematol. 2019 Sep;186(6):e212-e214. doi: 10.1111/bjh.16103. Epub 2019 Aug 1.
2
Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.新型托珠单抗靶向巨噬细胞活化以阻断输血后过度溶血。
Transfusion. 2020 Jan;60(1):30-35. doi: 10.1111/trf.15562. Epub 2019 Oct 23.
3
Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease.替代补体途径在镰状细胞病延迟性溶血性输血反应中的作用。
Haematologica. 2018 Oct;103(10):e483-e485. doi: 10.3324/haematol.2018.194670. Epub 2018 May 24.
4
Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.依库珠单抗挽救疗法用于镰状细胞病患者的迟发性溶血性输血反应
Blood. 2016 Feb 25;127(8):1062-4. doi: 10.1182/blood-2015-09-669770. Epub 2016 Jan 12.
5
Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.镰状细胞病中的高溶血性综合征：消除疑虑。
Med Princ Pract. 2021;30(3):236-243. doi: 10.1159/000512945. Epub 2020 Nov 11.
6
Anti-N and anti-Do immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.抗 N 和抗 Do 免疫球蛋白 G 同种异体抗体介导的迟发性溶血性输血反应伴镰状细胞病患者的严重溶血，使用依库珠单抗和 HBOC-201 治疗：病例报告及文献复习。
Transfusion. 2019 Jun;59(6):1907-1910. doi: 10.1111/trf.15198. Epub 2019 Feb 15.
7
Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.镰状细胞病患者输血后高溶血反应：使用类固醇和静脉注射免疫球蛋白预防进一步的红细胞破坏。
Vox Sang. 1995;69(4):355-7. doi: 10.1111/j.1423-0410.1995.tb00373.x.
8
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.镰状细胞病患者发生危及生命的迟发性溶血性输血反应：依库珠单抗继以利妥昔单抗治疗有效
Transfusion. 2015 Oct;55(10):2398-403. doi: 10.1111/trf.13144. Epub 2015 May 18.
9
Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.预防和治疗与红细胞输血相关的溶血并发症所面临的挑战。
Transfus Clin Biol. 2019 May;26(2):130-134. doi: 10.1016/j.tracli.2019.03.002. Epub 2019 Mar 25.
10
Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.一名镰状细胞病患者发生多次溶血性输血反应，却被误诊为严重血管闭塞危象。
Transfusion. 2019 Feb;59(2):448-453. doi: 10.1111/trf.15010. Epub 2018 Nov 9.

引用本文的文献

1
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature.镰状细胞病中高溶血的应对策略：文献综述
Diagnostics (Basel). 2025 Jul 21;15(14):1835. doi: 10.3390/diagnostics15141835.
2
Alloimmunization and hyperhemolysis in sickle cell disease.镰状细胞病中的同种免疫与高红细胞溶血。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):653-659. doi: 10.1182/hematology.2023000499.
3
Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report.
托珠单抗联合利妥昔单抗成功治疗非输血依赖型地中海贫血严重溶血：一例报告
Transfus Med Hemother. 2022 Jun 30;50(1):66-70. doi: 10.1159/000524743. eCollection 2023 Feb.
4
Transfusion therapy for sickle cell disease: what's new?镰状细胞病的输血治疗：有哪些新进展？
Blood Adv. 2023 Jun 13;7(11):2551-2553. doi: 10.1182/bloodadvances.2022009283.
5
Adverse events of red blood cell transfusions in patients with sickle cell disease.镰状细胞病患者输血的不良反应。
Transfus Apher Sci. 2022 Oct;61(5):103557. doi: 10.1016/j.transci.2022.103557. Epub 2022 Aug 29.
6
Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature.一名已知患有镰状细胞贫血的患者出现急性高溶血综合征，对类固醇和静脉注射免疫球蛋白治疗无效，采用托珠单抗和促红细胞生成素治疗：病例报告及文献综述
Hematol Rep. 2022 Jul 21;14(3):235-239. doi: 10.3390/hematolrep14030032.
7
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.镰状细胞病合并近期 SARS-CoV-2 感染患者出现严重溶血，经复杂的自身抗体和同种异体抗体检测，并用托珠单抗成功治疗。
Transfusion. 2022 Jul;62(7):1446-1451. doi: 10.1111/trf.16932. Epub 2022 May 30.
8
Hyperhemolysis in the Setting of Mixed-Autoimmune Hemolytic Anemia: A Rare Complication of COVID-19.混合性自身免疫性溶血性贫血背景下的高溶血：新型冠状病毒肺炎的一种罕见并发症
Cureus. 2021 Dec 12;13(12):e20356. doi: 10.7759/cureus.20356. eCollection 2021 Dec.
9
Red cell transfusion and alloimmunization in sickle cell disease.镰状细胞病中的红细胞输血与同种免疫
Haematologica. 2021 Jul 1;106(7):1805-1815. doi: 10.3324/haematol.2020.270546.
10
Automated Red Cell Exchange in the Management of Sickle Cell Disease.镰状细胞病管理中的自动红细胞置换
J Clin Med. 2021 Feb 15;10(4):767. doi: 10.3390/jcm10040767.